Pharmacyte Biotech Inc. (PMCB)
NASDAQ · Healthcare
Pharmacyte Biotech Inc. Total Liabilities 2011–2025
Pharmacyte Biotech Inc. annual total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Pharmacyte Biotech Inc. total liabilities as of April 30, 2025: 3.3M, a 83.93% decrease year-over-year.
- Pharmacyte Biotech Inc. total liabilities for 2025 were 3.3M, a 83.93% decrease from 2024.
- Pharmacyte Biotech Inc. total liabilities for 2024 were 20.4M, a 3375.95% increase from 2023.
- Pharmacyte Biotech Inc. total liabilities for 2023 were 586,581, a 16.72% decrease from 2022.
- Pharmacyte Biotech Inc. total liabilities for 2022 were 704,370.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pharmacyte Biotech Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $20 |
| 2023 | $1 |
| 2022 | $1 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $1 |
| 2018 | $1 |
| 2017 | $1 |
| 2016 | $1 |
| 2015 | $2 |
| 2014 | $0 |
| 2013 | $4 |
| 2012 | $4 |
| 2011 | $3 |
Pharmacyte Biotech Inc. Total Liabilities — FAQ
Pharmacyte Biotech Inc. (PMCB) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PMCB's total liabilities history?
The chart and table above show Pharmacyte Biotech Inc.'s total liabilities by year and by quarter, including the growth rate.